SEHK:867Pharmaceuticals
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative
China Medical System Holdings (SEHK:867) has put fresh numbers on the table for FY 2025, posting first half revenue of C¥4.0b and basic EPS of C¥0.39, alongside trailing twelve month revenue of C¥7.9b and EPS of C¥0.68. The company has seen revenue move from C¥3.6b in the first half of FY 2024 to C¥4.0b in the first half of FY 2025 and trailing revenue shift from C¥7.5b to C¥7.9b, with basic EPS across reported halves ranging between C¥0.29 and C¥0.39. For you as an investor, the key question...